FDA recently proposed updates to its regulations to clarify the types of evidence the agency considers when determining the “intended use” of FDA-regulated products.
The proposed...
Bristol Myers Squibb recently announced that more than half (53.4 percent) of advanced renal cell carcinoma patients treated with an immunotherapy combination of Opdivo (nivolumab) and Yervoy...
Microsoft and C.H. Robinson recently partnered to transform supply chains of the future and enable real-time visibility for C.H. Robinson customers.
To meet the demands of evolving global supply...
The German Pharmaceutical Market Restructuring Act (AMNOG) is an example of how a drug pricing strategy can be designed to better align prices with clinical benefit and is an approach the US can take...
Gilead Sciences recently found that using remdesivir as a COVID-19 treatment for severe coronavirus patients produced positive results in a Phase 3 clinical trial. Severe coronavirus patients receiving...
Pharmacy benefit manager (PBM) reimbursement for generic drugs significantly varies by medication and plan, and does not respond to price hikes, according to a study from 3 Axis Advisors.
Researchers...
Alnylam and Dicerna recently announced the development and commercialization of investigational RNAi therapeutics for the treatment of alpha-1 liver disease.
The pharmaceutical companies have also...
FDA recently announced that it issued a guidance for industry, investigators, and institutional review boards conducting clinical trials during the COVID-19 pandemic.
For more coronavirus updates,...
Vizient recently announced it has sent recommendations to the White House Coronavirus Task Force and FDA to improve access for two potential COVID-19 drugs: chloroquine and hydroxychloroquine.
For...
Biopharmaceutical companies spent an estimated $985 million on new drug development and research over a decade, counting expenditures on failed trials, according to researchers from the London School...
The Department of Justice recently announced that it has charged generic pharmaceutical company Sandoz Inc. for fixing generic drug prices, rigging bids, and other antitrust...
Law firm Lieff Cabraser, Heimann & Bernstein recently filed a wrongful death lawsuit against biopharmaceutical manufacturer Alkermes, for its alleged misrepresentation of an opioid dependence drug,...
Germany-based pharmaceutical company, Stada, announced it acquired 15 well-established local and regional consumer over-the-counter (OTC) products from GlaxoSmithKline (GSK).
The proposed...
With the prevalence of antibiotic resistance rapidly rising, a new study published in Cell is offering a more efficient, cost-efficient strategy for antibiotic discovery using machine learning.
There...
